Table 3.
MMP14 expression in CAFs at the TSI |
MMP14 expression in the tumour nest at the TSI | MMP14 co-scoring system | |||||||
---|---|---|---|---|---|---|---|---|---|
Negative | Positive | p | Low | High | p | Low- risk | High- risk | p | |
pT | < 0.001 | 0.44 | < 0.01 | ||||||
1.2 | 16 | 1 | 10 | 7 | 17 | 0 | |||
3.4 | 16 | 38 | 26 | 28 | 30 | 24 | |||
pDOI | < 0.001 | 0.22 | 0.22 | ||||||
≤ 10 mm | 17 | 4 | 13 | 8 | 13 | 8 | |||
> 10 mm | 15 | 35 | 23 | 27 | 23 | 27 | |||
Lymph node metastasis | < 0.001 | 0.02 | < 0.001 | ||||||
(-) | 21 | 5 | 18 | 8 | 25 | 1 | |||
(+) | 11 | 34 | 18 | 27 | 22 | 23 | |||
pN | < 0.001 | 0.02 | < 0.01 | ||||||
0,1 | 24 | 14 | 24 | 14 | 31 | 7 | |||
2,3 | 8 | 25 | 12 | 21 | 16 | 17 | |||
ENE | < 0.01 | < 0.001 | < 0.001 | ||||||
(-) | 26 | 18 | 30 | 14 | 37 | 7 | |||
(+) | 6 | 21 | 6 | 21 | 10 | 17 | |||
Differentiation | 0.37 | 0.37 | 0.58 | ||||||
Well | 17 | 28 | 24 | 21 | 27 | 18 | |||
Moderate | 13 | 11 | 12 | 12 | 18 | 6 | |||
Poor | 2 | 0 | 0 | 2 | 2 | 0 | |||
Invasion pattern | 0.03 | 0.06 | 0.047 | ||||||
1.2 | 6 | 1 | 6 | 1 | 7 | 0 | |||
3.4c.4d | 26 | 38 | 30 | 34 | 40 | 24 | |||
DR | < 0.001 | 0.12 | 0.21 | ||||||
Mature | 17 | 6 | 22 | 15 | 27 | 10 | |||
Immature | 15 | 33 | 14 | 20 | 20 | 14 | |||
TB | 0.02 | < 0.01 | < 0.01 | ||||||
Low | 19 | 12 | 23 | 8 | 28 | 3 | |||
High | 13 | 27 | 13 | 27 | 19 | 21 | |||
TILs | 0.02 | 0.54 | 0.08 | ||||||
High | 19 | 12 | 17 | 14 | 24 | 7 | |||
Low | 13 | 27 | 19 | 21 | 23 | 17 | |||
Ly | < 0.001 | 0.01 | 0.01 | ||||||
(-) | 15 | 5 | 15 | 5 | 15 | 5 | |||
(+) | 17 | 34 | 21 | 30 | 21 | 30 | |||
V | < 0.001 | 0.05 | 0.06 | ||||||
(-) | 16 | 1 | 12 | 5 | 12 | 5 | |||
(+) | 16 | 38 | 24 | 30 | 24 | 30 | |||
Pn | < 0.001 | 0.04 | 0.048 | ||||||
(-) | 16 | 6 | 15 | 7 | 15 | 7 | |||
(+) | 16 | 33 | 21 | 28 | 21 | 28 |
CAFs, cancer-associated fibroblasts; OSCC, oral squamous cell carcinoma; TSI, tumour–stromal interface; pT, pathological T; pDOI, pathological depth of invasion; pN, pathological N; DR, depth of invasion; TB, tumour budding; TILs, tumour-infiltrating lymphocytes; Ly, lymphatic invasion; V, vascular invasion; p, p-value; Pn, perineural invasion. Boldface indicates statistically significant values